<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id>
<journal-title>Frontiers in Endocrinology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Endocrinol.</abbrev-journal-title>
<issn pub-type="epub">1664-2392</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fendo.2023.1199589</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Endocrinology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Association of growth hormone deficiency with an increased number of preadipocytes in subcutaneous fat</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Lidan</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jia</surname>
<given-names>Dan</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tan</surname>
<given-names>Zhendong</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/1697476"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Jiang</surname>
<given-names>Honglin</given-names>
</name>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1402471"/>
</contrib>
</contrib-group>    <aff id="aff1">
<institution>School of Animal Sciences, Virginia Tech</institution>, <addr-line>Blacksburg, VA</addr-line>, <country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Daniel J. Bernard, McGill University, Canada</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Luisina Ongaro, McGill University, Canada; Gwen V. Childs, University of Arkansas for Medical Sciences, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Honglin Jiang, <email xlink:href="mailto:hojiang@vt.edu">hojiang@vt.edu</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>05</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1199589</elocation-id>
<history>
<date date-type="received">
<day>03</day>
<month>04</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>05</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Zhao, Jia, Tan and Jiang</copyright-statement>    <copyright-year>2023</copyright-year>
<copyright-holder>Zhao, Jia, Tan and Jiang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>The inhibitory effect of growth hormone (GH) on adipose tissue growth is well known, but the underlying mechanism is not fully understood. In this study, we determined the possibility that GH inhibits adipose tissue growth by inhibiting adipogenesis, the process of formation of adipocytes from stem cells, in the lit/lit mice. The lit/lit mice are GH deficient because of a spontaneous mutation to the GH releasing hormone receptor (ghrhr) gene, and they have more subcutaneous fat despite being smaller than the lit/+ mice at the same age. We found that cells of the stromal vascular fraction (SVF) of subcutaneous fat from the lit/lit mice had greater adipogenic potential than those from the lit/+ mice, as evidenced by forming greater numbers of lipid droplets-containing adipocytes and having greater expression of adipocyte marker genes during induced adipocyte differentiation in culture. However, addition of GH to the culture did not reverse the superior adipogenic potential of subcutaneous SVF from the lit/lit mice. Through florescence-activated cell sorting and quantification of mRNAs of preadipocyte markers, including CD34, CD29, Sca-1, CD24, Pref-1, and PPAR&#x3b3;, we found that subcutaneous SVF from the lit/lit mice contained more preadipocytes than that from the lit/+ mice. These results support the notion that GH inhibits adipose tissue growth in mice at least in part by inhibiting adipogenesis. Furthermore, these results suggest that GH inhibits adipogenesis in mice not by inhibiting the terminal differentiation of preadipocytes into adipocytes, rather by inhibiting the formation of preadipocytes from stem cells or the recruitment of stem cells to the fat depot.</p>
</abstract>
<kwd-group>
<kwd>preadipocyte</kwd>
<kwd>adipogenesis</kwd>
<kwd>growth hormone</kwd>
<kwd>stromal vascular fraction</kwd>
<kwd>mice</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="58"/>
<page-count count="10"/>
<word-count count="4175"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Pituitary Endocrinology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>The inhibitory effect of growth hormone (GH), also known as somatotropin, on adipose tissue growth has been demonstrated in different species. In rats, administration of pituitary GH reduced body fat while increasing lean body mass (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). In obese mice, GH treatment reduced body fat mass in a dose-dependent manner (<xref ref-type="bibr" rid="B3">3</xref>). In GH receptor (GHR) null mice, fat mass percentage was markedly elevated (<xref ref-type="bibr" rid="B4">4</xref>). In pigs, administration of exogenous GH decreased body fat mass by as much as 70% (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>). In cattle, administration of GH from 0 to 160 mg/week decreased linearly the deposition of subcutaneous fat, visceral fat, and intramuscular fat (<xref ref-type="bibr" rid="B7">7</xref>). Maison et&#xa0;al. concluded that GH had significant fat mass-reducing effects in humans too after reviewing thirty-seven trials where GH treatment was given to adult patients with GH deficiency (<xref ref-type="bibr" rid="B8">8</xref>).</p>
<p>Adipose tissue grows <italic>via</italic> both hypertrophy and hyperplasia (<xref ref-type="bibr" rid="B9">9</xref>). Hypertrophy in adipose tissue is determined by the balance between lipogenesis, the process of triglyceride synthesis, and lipolysis, the process of triglyceride breakdown (<xref ref-type="bibr" rid="B10">10</xref>). Hyperplasia in adipose tissue is determined by proliferation of preadipocytes, the adipocyte precursor cells, terminal differentiation of preadipocytes to adipocytes, and apoptosis of preadipocytes and adipocytes (<xref ref-type="bibr" rid="B11">11</xref>). Increasing evidence suggests that GH inhibits adipose tissue growth by affecting more than one of these processes. Growth hormone has potent lipolytic effects in animals, although the underlying mechanism is not clear (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>). Earlier studies suggested that GH enhanced catecholamine-stimulated lipolysis (<xref ref-type="bibr" rid="B14">14</xref>&#x2013;<xref ref-type="bibr" rid="B17">17</xref>), but more recent studies suggested that GH stimulates lipolysis by activating peroxisome proliferator activated receptor &#x3b3; (PPAR&#x3b3;), which then inhibits the expression of fat-specific protein 27 (FSP27) in adipose tissue (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>). Growth hormone reduces fat mass also by suppressing lipogenesis. The inhibitory effect of GH on lipogenesis has been well demonstrated in pigs (<xref ref-type="bibr" rid="B20">20</xref>&#x2013;<xref ref-type="bibr" rid="B25">25</xref>). Mechanistically, GH inhibits lipogenesis by antagonizing the stimulatory effect of insulin on lipogenesis (<xref ref-type="bibr" rid="B26">26</xref>).</p>
<p>In theory, GH could inhibit adipose tissue growth by inhibiting adipogenesis, the process of formation of adipocytes (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>). However, studies on this possibility have generated seemingly conflicting results. Whereas studies in primary preadipocyte culture indicated an inhibitory effect of GH on preadipocyte differentiation into adipocytes (<xref ref-type="bibr" rid="B29">29</xref>&#x2013;<xref ref-type="bibr" rid="B31">31</xref>), studies in preadipocyte cell lines, such as 3T3-L1, 3T3-F442A, and Ob1771, revealed a stimulatory effect of GH on this process (<xref ref-type="bibr" rid="B32">32</xref>&#x2013;<xref ref-type="bibr" rid="B36">36</xref>). These controversies beg additional studies to clarify the effect of GH on adipogenesis.</p>
<p>In this study, we determined the effect of GH on adipogenesis in the GH-deficient lit/lit mice. The lit/lit mice carry a mutation that disable the GH releasing hormone receptor (<italic>ghrhr</italic>) gene, and as such, mice homozygous for the mutation (lit/lit) are deficient in GH and smaller than wild-type or lit/+ mice (<xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B38">38</xref>). In a previous study, we found that the lit/lit mice had more subcutaneous fat than the lit/+ mice despite being much smaller than the latter (<xref ref-type="bibr" rid="B39">39</xref>). In this study, we found that the lit/lit mice accumulated more preadipocytes in subcutaneous fat but that terminal differentiation of preadipocytes from the lit/lit mice into adipocytes was not affected by GH <italic>in vitro</italic>.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="s2_1">
<title>Mice and adipose tissue collection</title>
<p>Breeding pairs of C57BL/6J-Ghrhr<sup>lit</sup> mice, a lit/lit female and a lit/+ male, were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). Mice were housed on an automatically timed 12&#xa0;h light/dark cycle at 23&#xb0;C with free access to standard rodent chow and water. Male lit/+ littermates were used as controls for lit/lit mice because wild-type littermates were not available from the breeding program and because lit/+ mice did not differ from wild-type mice in body weight (<xref ref-type="bibr" rid="B38">38</xref>). Mice were euthanized by CO<sub>2</sub> inhalation and cervical dislocation. Euthanasia was performed between 9:00 a.m. and 11:00 a.m. Mice were euthanized for collection of the inguinal fat pads. The inguinal fat pads in this study referred to the subcutaneous fat pads between the lumbar spine and the groin. All animal-related procedures were approved by the Virginia Tech Institutional Animal Care and Use Committee.</p>
</sec>
<sec id="s2_2">
<title>Isolation and culture of stromal vascular fraction</title>
<p>The stromal vascular fraction (SFV) of adipose tissue was isolated as previously described with minor modifications (<xref ref-type="bibr" rid="B40">40</xref>). Fat pads were minced and digested using 1 mg/ml of collagenase D (Roche, Indianapolis, IN, USA) in HEPES buffer (100 mM HEPES pH 7.4, 120 mM NaCl, 50 mM KCl, 0.5 mM glucose, 1.5% bovine serum albumin, and 1 mM CaCl<sub>2</sub>) at 37 &#xb0;C with shaking at 115 rpm for 1&#xa0;h. After centrifugation at 500 &#xd7;g for 10&#xa0;min at room temperature, the pelleted SVF was washed twice with growth medium consisting of Dulbecco&#x2019;s Modified Eagle&#x2019;s Medium (DMEM)/F12 (Sigma-Aldrich, St. Louis, MO, USA), 10% fetal bovine serum or FBS (Atlanta Biologicals, Lawrenceville, GA, USA), 2.5 mM of L-glutamine, and 1% of antibiotics-antimycotics or ABAM (Mediatech, Manassas, VA, USA).</p>
<p>The SVF cells were initially cultured in growth medium in a CO2 incubator at 37 &#xb0;C. Four or 5 days later, the SVF cells from the same mouse were collected and reseeded in 6- or 24-well plates at a density of 25,000/cm<sup>2</sup>. When cells reached 100% confluence, they were induced to differentiate into adipocytes using the previously described method (<xref ref-type="bibr" rid="B40">40</xref>). This method included initially culturing the cells in the DMEM/F12 medium supplemented with 5% FBS, 17 nM insulin (Sigma-Aldrich), 0.1 &#x3bc;M dexamethasone (Sigma-Aldrich), 250 &#x3bc;M 3-isobutyo-1-methylxanthine (IBMX) (Sigma-Aldrich), and 60 &#x3bc;M indomethacin (MP Biomedical, Solon, OH, USA) for two days, then in DMEM/F12 medium supplemented with 17 nM insulin and 10% FBS for another two days, and lastly in DMEM/F12 supplemented with 10% FBS for four days. Each cell culture experiment was repeated 3 or 4 times, each time using cells isolated from different lit/lit or lit/+ mice.</p>
</sec>
<sec id="s2_3">
<title>Oil Red O staining</title>
<p>Cells were washed with phosphate buffered saline (PBS) twice and fixed with 10% phosphate buffered formalin (Fisher Scientific, Pittsburg, PA, USA) for 1&#xa0;h. Cells were washed first with water and then 60% isopropanol (Fisher Scientific). Cells were stained with 2.1 mg/ml Oil Red O solution prepared in 60% isopropanol for 1&#xa0;h and then washed with water as previously described (<xref ref-type="bibr" rid="B41">41</xref>).</p>
</sec>
<sec id="s2_4">
<title>RNA isolation and real-time PCR</title>
<p>Total RNA from cultured adipocytes was isolated using TRI reagent (Invitrogen, Grand island, NY, USA) according to the manufacture&#x2019;s instruction. Total RNA (1 &#x3bc;g/reaction) was reverse-transcribed into cDNA using ImProm-II Reverse Transcription system (Promega, Madison, Wisconsin, USA). cDNA (20 ng/reaction) was quantified by PCR using gene-specific primers (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>) and Fast SYBRGreen Master Mix on an Applied Biosystems 7500 Real-Time PCR machine (Applied Biosystems, Foster City, CA, USA). Specificity of primers was validated by gel electrophoresis and DNA sequencing of PCR products, and efficiency of primers was validated by amplifying a serial dilution of cDNA. Each sample was quantified in duplicate. The PCR data were analyzed using the 2(-&#x394;&#x394;Ct) method (<xref ref-type="bibr" rid="B42">42</xref>). The mouse <italic>hmbs</italic> gene was chosen as the reference gene because, based on the Ct values, its mRNA expression was stable across the samples.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>PCR primers used in this study.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Gene</th>
<th valign="top" align="center">Primer sequence (5&#x2019; to 3&#x2019;)</th>
<th valign="top" align="center">GenBank #</th>
<th valign="top" align="center">Amplicon size (bp)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" rowspan="2" align="left">
<italic>pparg</italic>
</td>
<td valign="top" align="left">Forward: TTCAGAAGTGCCTTGCTGTG</td>
<td valign="top" rowspan="2" align="left">NM_001127330.1</td>
<td valign="top" rowspan="2" align="left">84</td>
</tr>
<tr>
<td valign="top" align="left">Reverse: CCAACAGCTTCTCCTTCTCG</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">
<italic>cebpa</italic>
</td>
<td valign="top" align="left">Forward: AGCAACGAGTACCGGGTACG</td>
<td valign="top" rowspan="2" align="left">NM_007678.3</td>
<td valign="top" rowspan="2" align="left">71</td>
</tr>
<tr>
<td valign="top" align="left">Reverse: TGTTTGGCTTTATCTCGGCTC</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">
<italic>lipe</italic>
</td>
<td valign="top" align="left">Forward: TCGCTGTTCCTCAGAGACCT</td>
<td valign="top" rowspan="2" align="left">NM_001039507</td>
<td valign="top" rowspan="2" align="left">151</td>
</tr>
<tr>
<td valign="top" align="left">Reverse: CTGCCTCAGACACACTCCTG</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">
<italic>plin1</italic>
</td>
<td valign="top" align="left">Forward<bold>
<sc>:</sc>
</bold> AAGGATCCTGCACCTCACAC</td>
<td valign="top" rowspan="2" align="left">NM_175640.2</td>
<td valign="top" rowspan="2" align="left">191</td>
</tr>
<tr>
<td valign="top" align="left">Reverse: CCTCTGCTGAAGGGTTATCG</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">
<italic>cd24</italic>
</td>
<td valign="top" align="left">Forward: ATGCCGCTATTGAATCTGCTGGAG</td>
<td valign="top" rowspan="2" align="left">NM_009846</td>
<td valign="top" rowspan="2" align="left">210</td>
</tr>
<tr>
<td valign="top" align="left">Reverse: TGCACTATGGCCTTATCGGTCAGA</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">
<italic>itgb1</italic>
</td>
<td valign="top" align="left">Forward: CAATGGCGTGTGCAGGTGTC</td>
<td valign="top" rowspan="2" align="left">NM_010578.2</td>
<td valign="top" rowspan="2" align="left">207</td>
</tr>
<tr>
<td valign="top" align="left">Reverse: ACGCCAAGGCAGGTCTGAC</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">
<italic>cd34</italic>
</td>
<td valign="top" align="left">Forward: GCAGGTCCACAGGGACACGC</td>
<td valign="top" rowspan="2" align="left">NM_001111059.1</td>
<td valign="top" rowspan="2" align="left">198</td>
</tr>
<tr>
<td valign="top" align="left">Reverse: TGGCTGGTACTTCCAGGGATGCT</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">
<italic>ly6a</italic>
</td>
<td valign="top" align="left">Forward: GGGACTGGAGTGTTACCAGTGCTA</td>
<td valign="top" rowspan="2" align="left">NM_010738.2</td>
<td valign="top" rowspan="2" align="left">166</td>
</tr>
<tr>
<td valign="top" align="left">Reverse: AGGAGGGCAGATGGGTAAGCAA</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">
<italic>dlk1</italic>
</td>
<td valign="top" align="left">Forward: GCGTGGACCTGGAGAAAGGCCA</td>
<td valign="top" rowspan="2" align="left">NM_010052.5</td>
<td valign="top" rowspan="2" align="left">276</td>
</tr>
<tr>
<td valign="top" align="left">Reverse: GGAAGTCACCCCCGATGTCGGT</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">
<italic>hbms</italic>
</td>
<td valign="top" align="left">Forward: AGAAAAGTGCCGTGGGAACC</td>
<td valign="top" rowspan="2" align="left">NM_013551.2</td>
<td valign="top" rowspan="2" align="left">107</td>
</tr>
<tr>
<td valign="top" align="left">Reverse: GAGGCGGGTGTTGAGGTTT</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2_5">
<title>Fluorescence-activated cell sorting</title>
<p>Preadipocytes from the mouse subcutaneous SVF were sorted and counted as previously described (<xref ref-type="bibr" rid="B43">43</xref>). To describe in brief, freshly isolated SVF cells were resuspended in ice-cold DMEM with 2% FBS and then incubated with the following antibodies at 1:100 dilution on ice for 15&#xa0;min: APC-Cy7 rat anti-mouse CD45 (Cat# 557659, RRID : AB_396774), PE-Cy7 rat anti-mouse CD31 (Cat# 561410, RRID : AB_10612003), PerCP-Cy5.5 rat anti-mouse TER-119/erythroid cells (Cat# 560512, RRID : AB_10561844), PE hamster anti-rat CD29 (Cat# 562154, RRID : AB_10897843), BV421 rat anti-mouse CD34 (Cat# 562608, RRID : AB_11154576), PE-CF594 rat anti-mouse Ly-6A/E (also known as Sca-1) (Cat# 562730, RRID : AB_2737751), and APC rat anti-mouse CD24 (Cat# 562349, RRID : AB_11151896), all from BD Biosciences (San Jose, CA, USA). Following the incubation, cells were washed with Hank&#x2019;s Balanced Salt Solution (HBSS) and then resuspended in HBSS supplemented with 0.5 g/ml propidium iodide (BD Biosciences). Cells were subsequently sorted on a BD FACSARIA Fusion Flow Cytometer equipped with BD FACSDiva Software (BD Biosciences). Cells were sorted first for singlets, followed by exclusion of propidium iodide-stained cells, i.e., dead cells. Live single cells were then sorted on the basis of cell-surface markers CD45, CD31, and TER-119. Cells negative for these markers (i.e., lineage negative or LIN&#x2212;) were then sorted based on their expression of CD29, CD34, Sca-1, and CD24, the cell surface markers for preadipocytes (<xref ref-type="bibr" rid="B43">43</xref>).</p>
</sec>
<sec id="s2_6">
<title>Statistical analyses</title>
<p>Data from multiple groups were analyzed by ANOVA followed by Tukey&#x2019;s test. Data from two groups were analyzed by <italic>t</italic>-test. These analyses were performed using the General Linear Model in JMP (SAS Institute Inc., Cary, NC, USA). The experimental units for all experiments in this study were mice. All data are expressed as the mean &#xb1; standard error (SE).</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>Stromal vascular fractions from the lit/lit mice had greater adipogenic potential than those from the lit/+ mice</title>
<p>The subcutaneous fat SVFs isolated from 13-week-old male lit/+ and lit/lit mice were induced to differentiate into adipocytes in culture. During the 8-day course of differentiation induction, the SVF cells from both the lit/lit and lit/+ mice underwent similar morphological changes: they both changed from the fibroblast-like shape to spherical shape, and they gradually accumulated lipid droplets (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>). However, it was apparent that a much greater portion of the SVF cells from the lit/lit mice became lipid droplets-containing adipocytes than that from the lit/+ mice at days 2 and 4 of differentiation (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>), and these differences were confirmed by Oil Red O staining of cells at day 8 of differentiation (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Differentiation of stromal vascular fraction (SVF) of subcutaneous fat from lit/+ and lit/lit mice to adipocytes. Stromal vascular fractions were isolated from inguinal subcutaneous fat pads of 13-week-old mice and were induced to differentiate to adipocytes in culture using a standard protocol (see text for details). This cell culture experiment was repeated 4 times, each time using SVF from a pair of lit/lit and lit/+ male mice. <bold>(A)</bold> Representative images of cells. Microscopic pictures were taken on day 0 (d0), d2, d4, and d8 of differentiation at 10x magnification. Cells on d8 of differentiation were stained with Oil Red O. <bold>(B)</bold> Expression levels of <italic>pparg</italic>, c<italic>ebpa</italic>, <italic>plin1</italic>, and <italic>lipe</italic> mRNAs in differentiating SVF cells. Relative abundance of mRNA was quantified by RT-qPCR. <italic>Cebpa</italic>, C/EBP&#x3b1;; <italic>pparg</italic>, PPAR&#x3b3;; <italic>plin1</italic>, perilipin-1; <italic>lipe</italic>, lipase e, hormone sensitive type, also known as hormone sensitive lipase. Data are expressed as means &#xb1; SE (n = 4 mice). mRNA expression was significantly different between days for both lit/lit and lit/+ (<italic>P</italic> &lt; 0.01). *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01, and &#xa7;<italic>P</italic> &lt; 0.1 lit/lit <italic>vs</italic>. lit/+.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1199589-g001.tif"/>
</fig>
<p>To further assess the adipogenic potential of the subcutaneous fat SVF cells from the lit/lit and lit/+ mice, mRNAs of four adipocyte marker genes were quantified. These marker genes were peroxisome proliferator activated receptor &#x3b3; (<italic>pparg</italic>), CCAAT/enhancer-binding protein &#x3b1; (<italic>cebpa</italic>), perlipin-1 (<italic>plin1)</italic>, and hormone sensitive lipase (<italic>lipe</italic>). Genes <italic>pparg</italic> and c<italic>ebpa</italic> are two master transcriptional regulators of adipogenesis (<xref ref-type="bibr" rid="B27">27</xref>); genes <italic>plin1</italic> and <italic>lipe</italic> play an important role in lipid metabolism in adipocytes (<xref ref-type="bibr" rid="B44">44</xref>). At days 2, 4, and 8 of differentiation, almost all of these marker genes were expressed at much higher levels in the lit/lit than lit/+ SVF cells (<italic>P</italic> &lt; 0.05, <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>). These differences further indicated that the subcutaneous fat SVF cells from the lit/lit mice had much greater potential than those from the lit/+ mice at the same age to differentiate into adipocytes.</p>
</sec>
<sec id="s3_2">
<title>Growth hormone had no effect on the potential of the lit/lit SVF to differentiate into adipocytes in vitro</title>
<p>The aforementioned data that the subcutaneous fat SVF cells from the GH-deficient lit/lit mice had greater adipogenic potential than those from the GH-normal lit/+ mice suggested that GH inhibited subcutaneous fat adipogenesis in mice. To further determine the effect of GH on adipogenesis, we differentiated the subcutaneous fat SVF from the lit/lit mice into adipocytes in the presence of 100 ng/ml bovine GH, which was previously shown to be effective in stimulating liver IGF-I gene expression or inhibiting adipose tissue growth in mice (<xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B46">46</xref>). Surprisingly, based on the formation of lipid droplets-containing adipocytes (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>) and the expression levels of adipocyte marker genes (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>), GH addition had no significant effect on the differentiation of the lit/lit SVF cells into adipocytes in culture.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Effect of growth hormone (GH) on differentiation of stromal vascular fraction (SVF) from lit/lit mice to adipocytes. Stromal vascular fractions were isolated from inguinal subcutaneous fat pads of 14-week-old male lit/lit mice. Cells were induced to differentiate to adipocytes in the presence or absence of 100 ng/ml of recombinant bovine GH. This cell culture experiment was repeated 3 times, each time using SVF from a different mouse. <bold>(A)</bold> Representative pictures of cells. Microscopic pictures were taken on day 0 (d0), d2, d4, and d8 of adipocyte differentiation at 10x magnification. Cells on d8 of differentiation were stained with Oil red O. Note that there was no apparent difference in the formation of adipocytes between lit/lit and lit/lit+GH SVF. <bold>(B)</bold> Expression levels of <italic>pparg</italic>, c<italic>ebpa</italic>, <italic>lipe</italic> and <italic>plin1</italic> mRNAs in differentiating SVF cells. Data are expressed as means &#xb1; SE (n = 3 mice). The expression of these genes in both groups increased (<italic>P</italic> &lt; 0.03) during adipocyte differentiation; however, the expression of these genes was not different (<italic>P</italic> &gt; 0.8) between the two groups on the same days of differentiation.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1199589-g002.tif"/>
</fig>
</sec>
<sec id="s3_3">
<title>The SVF from the lit/lit mice contained more preadipocytes than that from the lit/+ mice</title>
<p>The SVF consists of several other types of cells in addition to preadipocytes (<xref ref-type="bibr" rid="B47">47</xref>). The aforementioned results that the SVF cells from the GH-deficient lit/lit mice had greater potential to become adipocytes than those from the GH-normal lit/+ mice yet that GH had no effect on the differentiation of the lit/lit SVF cells into adipocytes <italic>in vitro</italic> suggested that the lit/lit subcutaneous fat SVF might contain more preadipocytes, the adipocyte precursor cells, than the lit/+ subcutaneous fat SVF. To test this possibility, we first used FACS to compare the percentage of preadipocytes between the lit/lit and lit/+ SVFs. As shown in <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>, we sorted and counted preadipocytes in the SVF based on their expression of surface markers CD29, CD34, Sca-1, and CD24 (<xref ref-type="bibr" rid="B43">43</xref>). The SVF from the lit/lit mice contained more Ter119&#x2013;, CD31&#x2013;, and CD45&#x2013; cells, i.e., Lin&#x2013; cells, than the SVF from the lit/+ mice (<italic>P</italic> &lt; 0.05, <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). The SVF from the lit/lit mice had the tendency (<italic>P</italic> &lt; 0.18, n = 3) to contain more Lin&#x2013;, CD34+, CD29+, Sca-1+, and CD24+ cells, i.e., preadipocytes, than the SVF from the lit/+ mice (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). CD24&#x2212; preadipocytes are considered more committed toward becoming adipocytes than CD24+ preadipocytes (<xref ref-type="bibr" rid="B43">43</xref>, <xref ref-type="bibr" rid="B48">48</xref>). The percentage of Lin&#x2013;, CD29+, CD34+, Sca-1+, and CD24&#x2013; cells, i.e., the more committed preadipocytes, was not different between the lit/lit and lit/+ SVF (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Fluorescence-activated cell sorting (FACS) of subcutaneous adipose SVF from lit/+ and lit/lit mice. The SVFs were isolated from 3 16-week-old male lit/+ and 3 16-week-old male lit/lit mice. <bold>(A)</bold> Representative FACS staining profiles and gating (white lines) of subcutaneous adipose SVF from a lit/lit mouse. The propidium iodide (PI)-negative singlets, i.e., live singlets, were sorted first for lack of Ter119 and CD31 and then lack of CD45 on cell surface. Ter119&#x2212;, CD31&#x2212;, and CD45&#x2212; cells (i.e., Lin&#x2212; cells) were then sorted on the basis of expression of CD34 and CD29. CD34+ and CD29+ cells were further sorted for expression of Sca-1 and CD24. <bold>(B)</bold> The percentages of total live single SVF cells expressing the indicated markers. Results are shown as mean &#xb1; SE (n = 3 mice). *<italic>P</italic> = 0.06, &#x2020;<italic>P</italic> = 0.14-0.18, and &#xa7;<italic>P</italic> = 0.73 <italic>vs</italic>. lit/+.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1199589-g003.tif"/>
</fig>
<p>We also quantified the expression levels of <italic>cd29</italic>, <italic>cd24</italic>, <italic>itgb1, ly6a, dlk1</italic>, and <italic>pparg</italic> mRNAs in the subcutaneous fat SVF cells from the lit/lit and lit/+ mice. <italic>Itgb1, ly6a, dlk1</italic>, and <italic>pparg</italic> are genes encoding CD29, Sca-1, Pref-1, and PPAR&#x3b3;, respectively. Besides CD29, CD34, Sca-1, and CD24, which are cell surface proteins (<xref ref-type="bibr" rid="B43">43</xref>), Pref-1, a transmembrane protein and PPAR&#x3b3;, a nuclear protein, are also considered markers of preadipocytes (<xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B50">50</xref>). In particular, Pref-1 is considered an excellent preadipocyte marker because it is highly expressed in preadipocytes but silenced in adipocytes (<xref ref-type="bibr" rid="B51">51</xref>). As shown in <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>, <italic>cd29</italic>, <italic>itgb1, ly6a, dlk1</italic>, and <italic>pparg</italic> mRNAs were all expressed at higher levels in the lit/lit than in the lit/+ SVF cells (<italic>P</italic> &lt; 0.05); <italic>cd24</italic> mRNA expression had a tendency to be higher in the lit/lit than the lit/+ SVF cells (<italic>P</italic> &lt; 0.1, n = 4). These gene expression data further indicated that the subcutaneous fat SVF from the GH-deficient lit/lit mouse contained more preadipocytes than that from the GH-normal lit/+ mouse.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Quantification of mRNA levels of preadipocyte markers in subcutaneous adipose SVF cells. Stromal vascular fractions were isolated from inguinal subcutaneous fat pads of 16-week-old male lit/+ and lit/lit mice. mRNA expression was quantified by RT-qPCR. Data are expressed as means &#xb1; SE (n = 3 and 4 mice for lit/+ and lit/lit, respectively). *<italic>P</italic> &lt; 0.05, &#x2020;<italic>P</italic> = 0.07, and &#xa7;<italic>P</italic> = 0.23 <italic>vs</italic>. lit/+<italic>. Dlk1, itgb1, ly6a</italic>, and <italic>pparg</italic> are also known as Pref-1, CD29, Sca-1, and PPAR&#x3b3;, respectively.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1199589-g004.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>The inhibitory effect of GH on adipose tissue growth has been demonstrated by multiple studies (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B52">52</xref>, <xref ref-type="bibr" rid="B53">53</xref>), but the underlying mechanism is not fully understood. In a previous study, we found that the GH-deficient lit/lit mice were growth retarded overall but accumulated more subcutaneous fat compared to the GH-normal lit/+ mice at the same age (<xref ref-type="bibr" rid="B39">39</xref>). These phenotypes of the GH-deficient lit/lit mice are consistent with those of GHR-null mice (<xref ref-type="bibr" rid="B54">54</xref>) and similar to the body weight and body composition changes in GH-deficient humans (<xref ref-type="bibr" rid="B53">53</xref>, <xref ref-type="bibr" rid="B55">55</xref>). In this study, we aimed to gain new understanding of this mechanism by studying the effect of GH deficiency on adipose tissue growth in the lit/lit mice.</p>
<p>During the development of obesity, hypertrophy is considered to be the initial event (<xref ref-type="bibr" rid="B56">56</xref>). However, the existing adipocytes cannot enlarge infinitely; therefore, continuing increase of adipose tissue mass depends on the formation of new adipocytes from preadipocytes. Preadipocytes are the adipocyte precursor cells of adipose tissue SVF (<xref ref-type="bibr" rid="B49">49</xref>). We compared the differentiation potential of subcutaneous fat SVF cells from the lit/lit and age-matched lit/+ mice in vitro. Our experiments showed that the SVF cells from the lit/lit mice had greater potential to differentiate into adipocytes than those from the lit/+ mice, implying that GH inhibits adipogenesis in vivo. Similar implications have been inferred from studying SVF from the GHR-null mice and bovine GH-transgenic mice (<xref ref-type="bibr" rid="B57">57</xref>). Increased adipogenic potential of the lit/lit SVF could be attributable to the SVF containing more preadipocytes, or the existing preadipocytes being more sensitive to adipogenic hormones. However, we found that the increased ability of the lit/lit SVF cells to differentiate into adipocytes in response to a standard adipogenic cocktail was not reversed by GH at a supraphysiological concentration (100 ng/ml) in vitro. This result argues against the possibility that GH inhibits adipogenesis in mice by directly inhibiting the sensitivity of existing preadipocytes to adipogenic hormones. This result, however, does not rule out the possibility that GH inhibits differentiation of preadipocytes into adipocytes in vivo through an indirect mechanism.</p>
<p>According to Rodeheffer and associates (<xref ref-type="bibr" rid="B43">43</xref>), preadipocytes in mouse white fat bear the following surface markers: Lin&#x2212;, CD29+, CD34+, Sca-1+, and CD24+. We used FACS to count preadipocytes in subcutaneous fat SVF from the lit/lit and lit/+ mice using antibodies against these markers and quantified the mRNA levels of these markers in these cells. In addition, we measured the mRNA levels of Pref-1 and PPAR&#x3b3;, two widely accepted markers of preadipocytes (<xref ref-type="bibr" rid="B49">49</xref>&#x2013;<xref ref-type="bibr" rid="B51">51</xref>). The data from both FACS and mRNA quantification indicated that SVF from the lit/lit subcutaneous fat contained more preadipocytes than that from the lit/+ subcutaneous fat. Preadipocytes in a fat depot could come from increased commitment of stem cells toward preadipocytes in the depot, increased recruitment of stem cells to the depot, or increased proliferation of preadipocytes in the depot. A previous study in C3H10T1/2 cells, which are pluripotent mesenchymal stem cells, supports the possibility that GH inhibits the commitment of stem cells to becoming preadipocytes (<xref ref-type="bibr" rid="B58">58</xref>). As a growth stimulating hormone, it is unlikely that GH somehow inhibits preadipocyte proliferation. It remains to be determined if GH also inhibits the recruitment of stem cells to the subcutaneous fat depot in mice.</p>
<p>It should be pointed out that this study is not without limitations. One limitation of this study is that only 3 or 4 mice per group were used, and some of the observations would be more rigorous if larger sample sizes were used. A second limitation of this study was that we did not investigate the mechanism by which GH inhibits the recruitment of stem cells to the subcutaneous fat depot or the commitment of recruited stem cells to preadipocytes. BMP2 and BMP4 have been shown to be essential for the commitment of mesenchymal stem cells to the adipocyte lineage (<xref ref-type="bibr" rid="B28">28</xref>); so, it is possible that GH inhibits the conversion of mesenchymal stem cells to preadipocytes by inhibiting BMP2 or BMP4 gene expression or their signaling. The Wnt/beta-catenin pathway is known to suppress the commitment of mesenchymal stem cells to the adipocyte lineage (<xref ref-type="bibr" rid="B28">28</xref>). A previous study showed that overexpression of bovine GH gene in mice was associated with increased expression of Axin2, a key mediator of Wnt/beta-catenin signaling (<xref ref-type="bibr" rid="B57">57</xref>); therefore, GH might inhibit the commitment of mesenchymal stem cells to preadipocytes by enhancing Wnt/beta-catenin signaling.</p>
<p>In summary, the results of this study support the conclusions that GH inhibits subcutaneous fat growth in mice in part by inhibiting adipogenesis and that GH inhibits the formation of adipocytes in subcutaneous fat in mice by inhibiting the accumulation of preadipocytes in the subcutaneous fat depot (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>). We propose that GH inhibits the accumulation of preadipocytes in subcutaneous fat by either inhibiting the recruitment of mesenchymal stem cells to the subcutaneous fat depot or inhibiting the commitment of mesenchymal stem cells to preadipocytes in the subcutaneous fat depot (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Model of how growth hormone (GH) inhibits subcutaneous adipogenesis in mice. It is hypothesized that GH inhibits the formation of adipocytes in mice by inhibiting the recruitment of mesenchymal stem cells (MSCs) to the subcutaneous fat depot, or the commitment of the multipotent MSCs to preadipocytes in the subcutaneous fat depot, or both. In this model, GH does not affect preadipocyte proliferation or terminal differentiation of preadipocytes into adipocytes.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1199589-g005.tif"/>
</fig>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The animal study was reviewed and approved by Virginia Tech IACUC.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>HJ conceived the study; LZ and HJ designed the experiments; LZ, DJ, and ZT conducted the experiments; LZ, DJ, and ZT analyzed the data; LZ and HJ wrote the manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
</body>
<back>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>LZ was supported, in part, by a Pratt fellowship from the College of Agriculture and Life Sciences Pratt Endowment at Virginia Tech.</p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>MO</given-names>
</name>
<name>
<surname>Shaffer</surname> <given-names>NK</given-names>
</name>
</person-group>. <article-title>Anterior pituitary growth hormone and the composition of growth</article-title>. <source>J Nutr</source> (<year>1934</year>) <volume>7</volume>:<page-range>337&#x2013;63</page-range>. doi: <pub-id pub-id-type="doi">10.1093/jn/7.3.337</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>CH</given-names>
</name>
<name>
<surname>Simpson</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Evans</surname> <given-names>HM</given-names>
</name>
</person-group>. <article-title>Influence of growth and adrenocorticotropic hormones on the body composition of hypophysectomized rats</article-title>. <source>Endocrinology</source> (<year>1949</year>) <volume>44</volume>(<issue>1</issue>):<page-range>71&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/endo-44-1-71</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>List</surname> <given-names>EO</given-names>
</name>
<name>
<surname>Palmer</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Berryman</surname> <given-names>DE</given-names>
</name>
<name>
<surname>Bower</surname> <given-names>B</given-names>
</name>
<name>
<surname>Kelder</surname> <given-names>B</given-names>
</name>
<name>
<surname>Kopchick</surname> <given-names>JJ</given-names>
</name>
</person-group>. <article-title>Growth hormone improves body composition, fasting blood glucose, glucose tolerance and liver triacylglycerol in a mouse model of diet-induced obesity and type 2 diabetes</article-title>. <source>Diabetologia</source> (<year>2009</year>) <volume>52</volume>(<issue>8</issue>):<page-range>1647&#x2013;55</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00125-009-1402-z</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berryman</surname> <given-names>DE</given-names>
</name>
<name>
<surname>List</surname> <given-names>EO</given-names>
</name>
<name>
<surname>Palmer</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Chung</surname> <given-names>MY</given-names>
</name>
<name>
<surname>Wright-Piekarski</surname> <given-names>J</given-names>
</name>
<name>
<surname>Lubbers</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Two-year body composition analyses of long-lived ghr null mice</article-title>. <source>J Gerontol A Biol Sci Med Sci</source> (<year>2010</year>) <volume>65</volume>(<issue>1</issue>):<fpage>31</fpage>&#x2013;<lpage>40</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/gerona/glp175</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Etherton</surname> <given-names>TD</given-names>
</name>
<name>
<surname>Wiggins</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Evock</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Chung</surname> <given-names>CS</given-names>
</name>
<name>
<surname>Rebhun</surname> <given-names>JF</given-names>
</name>
<name>
<surname>Walton</surname> <given-names>PE</given-names>
</name>
<etal/>
</person-group>. <article-title>Stimulation of pig growth performance by porcine growth hormone: determination of the dose-response relationship</article-title>. <source>J Anim Sci</source> (<year>1987</year>) <volume>64</volume>(<issue>2</issue>):<page-range>433&#x2013;43</page-range>. doi: <pub-id pub-id-type="doi">10.2527/jas1987.642433x</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Etherton</surname> <given-names>TD</given-names>
</name>
<name>
<surname>Louveau</surname> <given-names>I</given-names>
</name>
<name>
<surname>Sorensen</surname> <given-names>MT</given-names>
</name>
<name>
<surname>Chaudhuri</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Mechanisms by which somatotropin decreases adipose tissue growth</article-title>. <source>Am J Clin Nutr</source> (<year>1993</year>) <volume>58</volume>(<supplement>2 Suppl</supplement>):<page-range>287S&#x2013;95S</page-range>. doi: <pub-id pub-id-type="doi">10.1093/ajcn/58.2.287S</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Preston</surname> <given-names>RL</given-names>
</name>
<name>
<surname>Bartle</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Kasser</surname> <given-names>TR</given-names>
</name>
<name>
<surname>Day</surname> <given-names>JW</given-names>
</name>
<name>
<surname>Veenhuizen</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Baile</surname> <given-names>CA</given-names>
</name>
</person-group>. <article-title>Comparative effectiveness of somatotropin and anabolic steroids in feedlot steers</article-title>. <source>J Anim Sci</source> (<year>1995</year>) <volume>73</volume>(<issue>4</issue>):<page-range>1038&#x2013;47</page-range>. doi: <pub-id pub-id-type="doi">10.2527/1995.7341038x</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maison</surname> <given-names>P</given-names>
</name>
<name>
<surname>Griffin</surname> <given-names>S</given-names>
</name>
<name>
<surname>Nicoue-Beglah</surname> <given-names>M</given-names>
</name>
<name>
<surname>Haddad</surname> <given-names>N</given-names>
</name>
<name>
<surname>Balkau</surname> <given-names>B</given-names>
</name>
<name>
<surname>Chanson</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Impact of growth hormone (Gh) treatment on cardiovascular risk factors in gh-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials</article-title>. <source>J Clin Endocrinol Metab</source> (<year>2004</year>) <volume>89</volume>(<issue>5</issue>):<page-range>2192&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1210/jc.2003-030840</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lane</surname> <given-names>MD</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>QQ</given-names>
</name>
</person-group>. <article-title>From multipotent stem cell to adipocyte</article-title>. <source>Birth defects Res Part A Clin Mol teratol</source> (<year>2005</year>) <volume>73</volume>(<issue>7</issue>):<page-range>476&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/bdra.20150</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saponaro</surname> <given-names>C</given-names>
</name>
<name>
<surname>Gaggini</surname> <given-names>M</given-names>
</name>
<name>
<surname>Carli</surname> <given-names>F</given-names>
</name>
<name>
<surname>Gastaldelli</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>The subtle balance between lipolysis and lipogenesis: a critical point in metabolic homeostasis</article-title>. <source>Nutrients</source> (<year>2015</year>) <volume>7</volume>(<issue>11</issue>):<page-range>9453&#x2013;74</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu7115475</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prins</surname> <given-names>JB</given-names>
</name>
<name>
<surname>O'Rahilly</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Regulation of adipose cell number in man</article-title>. <source>Clin Sci (Lond)</source> (<year>1997</year>) <volume>92</volume>(<issue>1</issue>):<fpage>3</fpage>&#x2013;<lpage>11</lpage>. doi: <pub-id pub-id-type="doi">10.1042/cs0920003</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nielsen</surname> <given-names>TS</given-names>
</name>
<name>
<surname>Jessen</surname> <given-names>N</given-names>
</name>
<name>
<surname>Jorgensen</surname> <given-names>JO</given-names>
</name>
<name>
<surname>Moller</surname> <given-names>N</given-names>
</name>
<name>
<surname>Lund</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease</article-title>. <source>J Mol Endocrinol</source> (<year>2014</year>) <volume>52</volume>(<issue>3</issue>):<page-range>R199&#x2013;222</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1530/JME-13-0277</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moller</surname> <given-names>N</given-names>
</name>
<name>
<surname>Jorgensen</surname> <given-names>JO</given-names>
</name>
</person-group>. <article-title>Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects</article-title>. <source>Endocr Rev</source> (<year>2009</year>) <volume>30</volume>(<issue>2</issue>):<page-range>152&#x2013;77</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/er.2008-0027</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beauville</surname> <given-names>M</given-names>
</name>
<name>
<surname>Harant</surname> <given-names>I</given-names>
</name>
<name>
<surname>Crampes</surname> <given-names>F</given-names>
</name>
<name>
<surname>Riviere</surname> <given-names>D</given-names>
</name>
<name>
<surname>Tauber</surname> <given-names>MT</given-names>
</name>
<name>
<surname>Tauber</surname> <given-names>JP</given-names>
</name>
<etal/>
</person-group>. <article-title>Effect of long-term rhgh administration in gh-deficient adults on fat cell epinephrine response</article-title>. <source>Am J Physiol</source> (<year>1992</year>) <volume>263</volume>(<issue>3 Pt 1</issue>):<page-range>E467&#x2013;72</page-range>. doi: <pub-id pub-id-type="doi">10.1152/ajpendo.1992.263.3.E467</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marcus</surname> <given-names>C</given-names>
</name>
<name>
<surname>Bolme</surname> <given-names>P</given-names>
</name>
<name>
<surname>Micha-Johansson</surname> <given-names>G</given-names>
</name>
<name>
<surname>Margery</surname> <given-names>V</given-names>
</name>
<name>
<surname>Bronnegard</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Growth hormone increases the lipolytic sensitivity for catecholamines in adipocytes from healthy adults</article-title>. <source>Life Sci</source> (<year>1994</year>) <volume>54</volume>(<issue>18</issue>):<page-range>1335&#x2013;41</page-range>. doi: <pub-id pub-id-type="doi">10.1016/0024-3205(94)00512-5</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bjorntorp</surname> <given-names>P</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Eden</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Growth hormone treatment of hypophysectomized rats increases catecholamine-induced lipolysis and the number of beta-adrenergic receptors in adipocytes: no differences in the effects of growth hormone on different fat depots</article-title>. <source>Obes Res</source> (<year>1996</year>) <volume>4</volume>(<issue>5</issue>):<page-range>471&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1002/j.1550-8528.1996.tb00256.x</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Mulder</surname> <given-names>H</given-names>
</name>
<name>
<surname>Holm</surname> <given-names>C</given-names>
</name>
<name>
<surname>Eden</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Effects of growth hormone on the function of beta-adrenoceptor subtypes in rat adipocytes</article-title>. <source>Obes Res</source> (<year>2004</year>) <volume>12</volume>(<issue>2</issue>):<page-range>330&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/oby.2004.41</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kopchick</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Berryman</surname> <given-names>DE</given-names>
</name>
<name>
<surname>Puri</surname> <given-names>V</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>KY</given-names>
</name>
<name>
<surname>Jorgensen</surname> <given-names>JOL</given-names>
</name>
</person-group>. <article-title>The effects of growth hormone on adipose tissue: old observations, new mechanisms</article-title>. <source>Nat Rev Endocrinol</source> (<year>2020</year>) <volume>16</volume>(<issue>3</issue>):<page-range>135&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41574-019-0280-9</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname> <given-names>VM</given-names>
</name>
<name>
<surname>Vestergaard</surname> <given-names>ET</given-names>
</name>
<name>
<surname>Jessen</surname> <given-names>N</given-names>
</name>
<name>
<surname>Kolind-Thomsen</surname> <given-names>P</given-names>
</name>
<name>
<surname>Nellemann</surname> <given-names>B</given-names>
</name>
<name>
<surname>Nielsen</surname> <given-names>TS</given-names>
</name>
<etal/>
</person-group>. <article-title>Growth hormone acts along the ppargamma-Fsp27 axis to stimulate lipolysis in human adipocytes</article-title>. <source>Am J Physiol Endocrinol Metab</source> (<year>2019</year>) <volume>316</volume>(<issue>1</issue>):<page-range>E34&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajpendo.00129.2018</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lanna</surname> <given-names>DP</given-names>
</name>
<name>
<surname>Houseknecht</surname> <given-names>KL</given-names>
</name>
<name>
<surname>Harris</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Bauman</surname> <given-names>DE</given-names>
</name>
</person-group>. <article-title>Effect of somatotropin treatment on lipogenesis, lipolysis, and related cellular mechanisms in adipose tissue of lactating cows</article-title>. <source>J dairy Sci</source> (<year>1995</year>) <volume>78</volume>(<issue>8</issue>):<page-range>1703&#x2013;12</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3168/jds.S0022-0302(95)76795-9</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donkin</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Chiu</surname> <given-names>PY</given-names>
</name>
<name>
<surname>Yin</surname> <given-names>D</given-names>
</name>
<name>
<surname>Louveau</surname> <given-names>I</given-names>
</name>
<name>
<surname>Swencki</surname> <given-names>B</given-names>
</name>
<name>
<surname>Vockroth</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Porcine somatotrophin differentially down-regulates expression of the Glut4 and fatty acid synthase genes in pig adipose tissue</article-title>. <source>J Nutr</source> (<year>1996</year>) <volume>126</volume>(<issue>10</issue>):<page-range>2568&#x2013;77</page-range>. doi: <pub-id pub-id-type="doi">10.1093/jn/126.10.2568</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harris</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Dunshea</surname> <given-names>FR</given-names>
</name>
<name>
<surname>Bauman</surname> <given-names>DE</given-names>
</name>
<name>
<surname>Boyd</surname> <given-names>RD</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>SY</given-names>
</name>
<name>
<surname>Johnson</surname> <given-names>PA</given-names>
</name>
<etal/>
</person-group>. <article-title>Effect of in vivo somatotropin treatment of growing pigs on adipose tissue lipogenesis</article-title>. <source>J Anim Sci</source> (<year>1993</year>) <volume>71</volume>(<issue>12</issue>):<page-range>3293&#x2013;300</page-range>. doi: <pub-id pub-id-type="doi">10.2527/1993.71123293x</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yin</surname> <given-names>D</given-names>
</name>
<name>
<surname>Clarke</surname> <given-names>SD</given-names>
</name>
<name>
<surname>Peters</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Etherton</surname> <given-names>TD</given-names>
</name>
</person-group>. <article-title>Somatotropin-dependent decrease in fatty acid synthase mrna abundance in 3t3-F442a adipocytes is the result of a decrease in both gene transcription and mrna stability</article-title>. <source>Biochem J</source> (<year>1998</year>) <volume>331</volume>(<issue>Pt 3</issue>):<page-range>815&#x2013;20</page-range>. doi: <pub-id pub-id-type="doi">10.1042/bj3310815</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walton</surname> <given-names>PE</given-names>
</name>
<name>
<surname>Etherton</surname> <given-names>TD</given-names>
</name>
</person-group>. <article-title>Stimulation of lipogenesis by insulin in swine adipose tissue: antagonism by porcine growth hormone</article-title>. <source>J Anim Sci</source> (<year>1986</year>) <volume>62</volume>(<issue>6</issue>):<page-range>1584&#x2013;95</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2527/jas1986.6261584x</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walton</surname> <given-names>PE</given-names>
</name>
<name>
<surname>Etherton</surname> <given-names>TD</given-names>
</name>
<name>
<surname>Evock</surname> <given-names>CM</given-names>
</name>
</person-group>. <article-title>Antagonism of insulin action in cultured pig adipose tissue by pituitary and recombinant porcine growth hormone: potentiation by hydrocortisone</article-title>. <source>Endocrinology</source> (<year>1986</year>) <volume>118</volume>(<issue>6</issue>):<page-range>2577&#x2013;81</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/endo-118-6-2577</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Etherton</surname> <given-names>TD</given-names>
</name>
</person-group>. <article-title>The biology of somatotropin in adipose tissue growth and nutrient partitioning</article-title>. <source>J Nutr</source> (<year>2000</year>) <volume>130</volume>(<issue>11</issue>):<page-range>2623&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jn/130.11.2623</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosen</surname> <given-names>ED</given-names>
</name>
<name>
<surname>MacDougald</surname> <given-names>OA</given-names>
</name>
</person-group>. <article-title>Adipocyte differentiation from the inside out</article-title>. <source>Nat Rev Mol Cell Biol</source> (<year>2006</year>) <volume>7</volume>(<issue>12</issue>):<page-range>885&#x2013;96</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrm2066</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname> <given-names>QQ</given-names>
</name>
<name>
<surname>Lane</surname> <given-names>MD</given-names>
</name>
</person-group>. <article-title>Adipogenesis: from stem cell to adipocyte</article-title>. <source>Annu Rev Biochem</source> (<year>2012</year>) <volume>81</volume>:<page-range>715&#x2013;36</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-biochem-052110-115718</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wabitsch</surname> <given-names>M</given-names>
</name>
<name>
<surname>Heinze</surname> <given-names>E</given-names>
</name>
<name>
<surname>Hauner</surname> <given-names>H</given-names>
</name>
<name>
<surname>Shymko</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Teller</surname> <given-names>WM</given-names>
</name>
<name>
<surname>De Meyts</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Biological effects of human growth hormone in rat adipocyte precursor cells and newly differentiated adipocytes in primary culture</article-title>. <source>Metab: Clin Exp</source> (<year>1996</year>) <volume>45</volume>(<issue>1</issue>):<fpage>34</fpage>&#x2013;<lpage>42</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0026-0495(96)90197-3</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deslex</surname> <given-names>S</given-names>
</name>
<name>
<surname>Negrel</surname> <given-names>R</given-names>
</name>
<name>
<surname>Ailhaud</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Development of a chemically defined serum-free medium for differentiation of rat adipose precursor cells</article-title>. <source>Exp Cell Res</source> (<year>1987</year>) <volume>168</volume>(<issue>1</issue>):<fpage>15</fpage>&#x2013;<lpage>30</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0014-4827(87)90412-5</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hansen</surname> <given-names>LH</given-names>
</name>
<name>
<surname>Madsen</surname> <given-names>B</given-names>
</name>
<name>
<surname>Teisner</surname> <given-names>B</given-names>
</name>
<name>
<surname>Nielsen</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Billestrup</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Characterization of the inhibitory effect of growth hormone on primary preadipocyte differentiation</article-title>. <source>Mol Endocrinol</source> (<year>1998</year>) <volume>12</volume>(<issue>8</issue>):<page-range>1140&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1210/mend.12.8.0154</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morikawa</surname> <given-names>M</given-names>
</name>
<name>
<surname>Nixon</surname> <given-names>T</given-names>
</name>
<name>
<surname>Green</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Growth hormone and the adipose conversion of 3t3 cells</article-title>. <source>Cell</source> (<year>1982</year>) <volume>29</volume>(<issue>3</issue>):<page-range>783&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1016/0092-8674(82)90440-8</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawai</surname> <given-names>M</given-names>
</name>
<name>
<surname>Namba</surname> <given-names>N</given-names>
</name>
<name>
<surname>Mushiake</surname> <given-names>S</given-names>
</name>
<name>
<surname>Etani</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Nishimura</surname> <given-names>R</given-names>
</name>
<name>
<surname>Makishima</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Growth hormone stimulates adipogenesis of 3t3-L1 cells through activation of the Stat5a/5b-ppargamma pathway</article-title>. <source>J Mol Endocrinol</source> (<year>2007</year>) <volume>38</volume>(<issue>1-2</issue>):<fpage>19</fpage>&#x2013;<lpage>34</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1677/jme.1.02154</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yarwood</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Sale</surname> <given-names>EM</given-names>
</name>
<name>
<surname>Sale</surname> <given-names>GJ</given-names>
</name>
<name>
<surname>Houslay</surname> <given-names>MD</given-names>
</name>
<name>
<surname>Kilgour</surname> <given-names>E</given-names>
</name>
<name>
<surname>Anderson</surname> <given-names>NG</given-names>
</name>
</person-group>. <article-title>Growth hormone-dependent differentiation of 3t3-F442a preadipocytes requires janus Kinase/Signal transducer and activator of transcription but not mitogen-activated protein kinase or P70 S6 kinase signaling</article-title>. <source>J Biol Chem</source> (<year>1999</year>) <volume>274</volume>(<issue>13</issue>):<page-range>8662&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1074/jbc.274.13.8662</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doglio</surname> <given-names>A</given-names>
</name>
<name>
<surname>Dani</surname> <given-names>C</given-names>
</name>
<name>
<surname>Grimaldi</surname> <given-names>P</given-names>
</name>
<name>
<surname>Ailhaud</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Growth-hormone regulation of the expression of differentiation-dependent genes in preadipocyte Ob1771 cells</article-title>. <source>Biochem J</source> (<year>1986</year>) <volume>238</volume>(<issue>1</issue>):<page-range>123&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1042/bj2380123</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corin</surname> <given-names>RE</given-names>
</name>
<name>
<surname>Guller</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>KY</given-names>
</name>
<name>
<surname>Sonenberg</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Growth-hormone and adipose differentiation - growth hormone-induced antimitogenic state in 3t3-F442a preadipose cells</article-title>. <source>P Natl Acad Sci USA</source> (<year>1990</year>) <volume>87</volume>(<issue>19</issue>):<page-range>7507&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.87.19.7507</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Godfrey</surname> <given-names>P</given-names>
</name>
<name>
<surname>Rahal</surname> <given-names>JO</given-names>
</name>
<name>
<surname>Beamer</surname> <given-names>WG</given-names>
</name>
<name>
<surname>Copeland</surname> <given-names>NG</given-names>
</name>
<name>
<surname>Jenkins</surname> <given-names>NA</given-names>
</name>
<name>
<surname>Mayo</surname> <given-names>KE</given-names>
</name>
</person-group>. <article-title>Ghrh receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function</article-title>. <source>Nat Genet</source> (<year>1993</year>) <volume>4</volume>(<issue>3</issue>):<page-range>227&#x2013;32</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ng0793-227</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flurkey</surname> <given-names>K</given-names>
</name>
<name>
<surname>Papaconstantinou</surname> <given-names>J</given-names>
</name>
<name>
<surname>Miller</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Harrison</surname> <given-names>DE</given-names>
</name>
</person-group>. <article-title>Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2001</year>) <volume>98</volume>(<issue>12</issue>):<page-range>6736&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.111158898</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>L</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Growth hormone stimulates lipolysis in mice but not in adipose tissue or adipocyte culture</article-title>. <source>Front Endocrinol (Lausanne)</source> (<year>2022</year>) <volume>13</volume>:<elocation-id>1028191</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2022.1028191</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hausman</surname> <given-names>DB</given-names>
</name>
<name>
<surname>Park</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Hausman</surname> <given-names>GJ</given-names>
</name>
</person-group>. <article-title>Isolation and culture of preadipocytes from rodent white adipose tissue</article-title>. <source>Methods Mol Biol</source> (<year>2008</year>) <volume>456</volume>:<page-range>201&#x2013;19</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-1-59745-245-8_15</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moon</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Chung</surname> <given-names>CS</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>HG</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>TG</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>YJ</given-names>
</name>
<name>
<surname>Cho</surname> <given-names>CS</given-names>
</name>
</person-group>. <article-title>Inhibitory effect of (-)-Epigallocatechin-3-Gallate on lipid accumulation of 3t3-L1 cells</article-title>. <source>Obes (Silver Spring)</source> (<year>2007</year>) <volume>15</volume>(<issue>11</issue>):<page-range>2571&#x2013;82</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/oby.2007.309</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Livak</surname> <given-names>KJ</given-names>
</name>
<name>
<surname>Schmittgen</surname> <given-names>TD</given-names>
</name>
</person-group>. <article-title>Analysis of relative gene expression data using real-time quantitative pcr and the 2(-delta delta C(T)) method</article-title>. <source>Methods</source> (<year>2001</year>) <volume>25</volume>(<issue>4</issue>):<page-range>402&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodeheffer</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Birsoy</surname> <given-names>K</given-names>
</name>
<name>
<surname>Friedman</surname> <given-names>JM</given-names>
</name>
</person-group>. <article-title>Identification of white adipocyte progenitor cells in vivo</article-title>. <source>Cell</source> (<year>2008</year>) <volume>135</volume>(<issue>2</issue>):<page-range>240&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2008.09.036</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yeaman</surname> <given-names>SJ</given-names>
</name>
</person-group>. <article-title>Hormone-sensitive lipase&#x2013;a multipurpose enzyme in lipid metabolism</article-title>. <source>Biochim Biophys Acta</source> (<year>1990</year>) <volume>1052</volume>(<issue>1</issue>):<page-range>128&#x2013;32</page-range>. doi: <pub-id pub-id-type="doi">10.1016/0167-4889(90)90067-N</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eleswarapu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Gu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Growth hormone regulation of insulin-like growth factor-I gene expression may be mediated by multiple distal signal transducer and activator of transcription 5 binding sites</article-title>. <source>Endocrinology</source> (<year>2008</year>) <volume>149</volume>(<issue>5</issue>):<page-range>2230&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/en.2007-1344</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benencia</surname> <given-names>F</given-names>
</name>
<name>
<surname>Harshman</surname> <given-names>S</given-names>
</name>
<name>
<surname>Duran-Ortiz</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lubbers</surname> <given-names>ER</given-names>
</name>
<name>
<surname>List</surname> <given-names>EO</given-names>
</name>
<name>
<surname>Householder</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Male Bovine gh transgenic mice have decreased adiposity with an adipose depot-specific increase in immune cell populations</article-title>. <source>Endocrinology</source> (<year>2015</year>) <volume>156</volume>(<issue>5</issue>):<page-range>1794&#x2013;803</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/en.2014-1794</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riordan</surname> <given-names>NH</given-names>
</name>
<name>
<surname>Ichim</surname> <given-names>TE</given-names>
</name>
<name>
<surname>Min</surname> <given-names>WP</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Solano</surname> <given-names>F</given-names>
</name>
<name>
<surname>Lara</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis</article-title>. <source>J Trans Med</source> (<year>2009</year>) <volume>7</volume>:<elocation-id>29</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1479-5876-7-29</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berry</surname> <given-names>R</given-names>
</name>
<name>
<surname>Rodeheffer</surname> <given-names>MS</given-names>
</name>
</person-group>. <article-title>Characterization of the adipocyte cellular lineage in vivo</article-title>. <source>Nat Cell Biol</source> (<year>2013</year>) <volume>15</volume>(<issue>3</issue>):<page-range>302&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ncb2696</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Zeve</surname> <given-names>D</given-names>
</name>
<name>
<surname>Suh</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Bosnakovski</surname> <given-names>D</given-names>
</name>
<name>
<surname>Kyba</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hammer</surname> <given-names>RE</given-names>
</name>
<etal/>
</person-group>. <article-title>White fat progenitor cells reside in the adipose vasculature</article-title>. <source>Science</source> (<year>2008</year>) <volume>322</volume>(<issue>5901</issue>):<page-range>583&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.1156232</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hudak</surname> <given-names>CS</given-names>
</name>
<name>
<surname>Gulyaeva</surname> <given-names>O</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Park</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>L</given-names>
</name>
<name>
<surname>Kang</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Pref-1 marks very early mesenchymal precursors required for adipose tissue development and expansion</article-title>. <source>Cell Rep</source> (<year>2014</year>) <volume>8</volume>(<issue>3</issue>):<page-range>678&#x2013;87</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.celrep.2014.06.060</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smas</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Sul</surname> <given-names>HS</given-names>
</name>
</person-group>. <article-title>Pref-1, a protein containing egf-like repeats, inhibits adipocyte differentiation</article-title>. <source>Cell</source> (<year>1993</year>) <volume>73</volume>(<issue>4</issue>):<page-range>725&#x2013;34</page-range>. doi: <pub-id pub-id-type="doi">10.1016/0092-8674(93)90252-L</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiegand</surname> <given-names>BR</given-names>
</name>
<name>
<surname>Parrish</surname> <given-names>FC</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Swan</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Larsen</surname> <given-names>ST</given-names>
</name>
<name>
<surname>Baas</surname> <given-names>TJ</given-names>
</name>
</person-group>. <article-title>Conjugated linoleic acid improves feed efficiency, decreases subcutaneous fat, and improves certain aspects of meat quality in stress-genotype pigs</article-title>. <source>J Anim Sci</source> (<year>2001</year>) <volume>79</volume>(<issue>8</issue>):<page-range>2187&#x2013;95</page-range>. doi: <pub-id pub-id-type="doi">10.2527/2001.7982187x</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wabitsch</surname> <given-names>M</given-names>
</name>
<name>
<surname>Heinze</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Body fat in gh-deficient children and the effect of treatment</article-title>. <source>Horm Res</source> (<year>1993</year>) <volume>40</volume>(<issue>1-3</issue>):<fpage>5</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000183760</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berryman</surname> <given-names>DE</given-names>
</name>
<name>
<surname>List</surname> <given-names>EO</given-names>
</name>
<name>
<surname>Coschigano</surname> <given-names>KT</given-names>
</name>
<name>
<surname>Behar</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>JK</given-names>
</name>
<name>
<surname>Kopchick</surname> <given-names>JJ</given-names>
</name>
</person-group>. <article-title>Comparing adiposity profiles in three mouse models with altered gh signaling</article-title>. <source>Growth hormone IGF Res</source> (<year>2004</year>) <volume>14</volume>(<issue>4</issue>):<page-range>309&#x2013;18</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ghir.2004.02.005</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosen</surname> <given-names>T</given-names>
</name>
<name>
<surname>Bosaeus</surname> <given-names>I</given-names>
</name>
<name>
<surname>Tolli</surname> <given-names>J</given-names>
</name>
<name>
<surname>Lindstedt</surname> <given-names>G</given-names>
</name>
<name>
<surname>Bengtsson</surname> <given-names>BA</given-names>
</name>
</person-group>. <article-title>Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency</article-title>. <source>Clin Endocrinol</source> (<year>1993</year>) <volume>38</volume>(<issue>1</issue>):<fpage>63</fpage>&#x2013;<lpage>71</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2265.1993.tb00974.x</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fajas</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Adipogenesis: a cross-talk between cell proliferation and cell differentiation</article-title>. <source>Ann Med</source> (<year>2003</year>) <volume>35</volume>(<issue>2</issue>):<fpage>79</fpage>&#x2013;<lpage>85</lpage>. doi: <pub-id pub-id-type="doi">10.1080/07853890310009999</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olarescu</surname> <given-names>NC</given-names>
</name>
<name>
<surname>Berryman</surname> <given-names>DE</given-names>
</name>
<name>
<surname>Householder</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Lubbers</surname> <given-names>ER</given-names>
</name>
<name>
<surname>List</surname> <given-names>EO</given-names>
</name>
<name>
<surname>Benencia</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Gh action influences adipogenesis of mouse adipose tissue-derived mesenchymal stem cells</article-title>. <source>J Endocrinol</source> (<year>2015</year>) <volume>226</volume>(<issue>1</issue>):<fpage>13</fpage>&#x2013;<lpage>23</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1530/JOE-15-0012</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jia</surname> <given-names>D</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>W</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Growth hormone facilitates 5'-Azacytidine-Induced myogenic but inhibits 5'-Azacytidine-Induced adipogenic commitment in C3h10t1/2 mesenchymal stem cells</article-title>. <source>Growth hormone IGF Res</source> (<year>2018</year>) <volume>40</volume>:<fpage>9</fpage>&#x2013;<lpage>16</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ghir.2018.03.006</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>